- Randall "Randy" Sunberg and Denis Segota further expand firm's transactional capabilities in life sciences sector
Baker McKenzie has added highly regarded life sciences lawyers Randall "Randy" Sunberg and Denis Segota in New York, further expanding the firm's transactional capabilities in the life sciences sector.
Randy brings more than 35 years of experience advising life sciences clients ranging from biotech startups to multinational pharmaceutical and medical device companies. He structures and negotiates complex collaborations, joint ventures and licensing transactions, as well as equity investments and royalty monetization transactions. He also counsels on alternative financing arrangements and handles technical contractual arrangements for drug discovery, development, manufacturing and supply, marketing and co-promotion and outsourcing in the life sciences industry.
Denis brings more than 20 years of experience advising clients on M&A and private financing transactions. He represents both financial institutions and companies in royalty monetizations, venture capital and other private equity financing. In addition, he advises companies in the pharmaceutical and biotech sectors on joint ventures, strategic alliances, licensing and other partnering arrangements promoting the research, development, and commercialization of new products.
Randy and Denis join Baker McKenzie from Morgan Lewis. They will join the Firm's Healthcare Industry group and its North America Corporate & Securities practice. Randy will be the co-head of the firm’s North America Life Sciences practice. Randy and Denis will be members of the Firm's New York office but will operate out of Princeton, New Jersey, along the life sciences corridor.
"Randy and Denis are trusted advisers to companies across the life sciences sector, from biotech startups to global pharmaceutical companies," said Alan Zoccolillo, Chair of Baker McKenzie's North America Healthcare Industry Group and Chair of the Firm's North America Corporate & Securities Practice. "As healthcare companies look to grow in a hypercompetitive environment, they need pragmatic, business-focused solutions. Randy and Denis bring deep industry and technical knowledge that will immediately benefit our team and our clients."
Added Scott Brandman, Managing Partner of Baker McKenzie's New York office, "We are very pleased to add the talent, experience and capabilities of Randy and Denis to further strengthen our team in this rapidly evolving industry. They understand the unique challenges faced by industry players and what it takes to overcome them, and they are an excellent addition to our Firm."
Baker McKenzie's Healthcare Industry group includes more than 500 lawyers worldwide who advise many of the world's largest pharmaceutical, biotech, medical device and healthcare services companies on a range of issues including transactional matters, patents and brands, global transfer pricing and tax planning strategies, product liability, competition and trade, commercial agreements, data privacy, employment issues and market entry. For the past five years, Baker McKenzie has ranked No. 1 for healthcare M&A by volume, completing more cross-border deals than any other law firm in the world, and is ranked by Chambers in the top 10 law firms in the world in life sciences.
"Randy and Denis are standout additions to our global healthcare team, combining industry knowledge and technical skill to create solutions for clients," said Ben McLaughlin, Global Chair of Baker McKenzie's Healthcare Group. "Their transactional expertise, especially in relation to licensing, collaboration and strategic alliance arrangements, adds further depth to our global and US capabilities as we continue to serve as trusted advisors to our life sciences clients around the world."
"We are committed to building our healthcare team by adding leading practitioners in North America as we continue to elevate our capabilities for clients," said Colin Murray, Baker McKenzie's North American Chief Executive Officer. "Randy and Denis will expand our already-strong healthcare expertise, particularly in the life sciences transactional space."
Randy added, "I am thrilled to join Baker McKenzie's preeminent Healthcare practice," said Randy. "I look forward to working with my new colleagues in North America and around the world to provide best-in-class service to our clients."
"This is no doubt an exciting time to work in the healthcare industry as it continues to rapidly evolve and change," said Denis. "Baker McKenzie is extremely well positioned to provide top service for clients on a global basis, and I am very pleased to join the Firm."
Randy received his BA from Yale University and his JD from New York University School of Law. Denis received his BS from Rutgers University and his JD from Rutgers University School of Law.